US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

592.55

-69.0037-10.43%

Number of Gainers:- -

Number of Losers:4

Number of Flat:- -

PE:- -

High:657.80

Open:657.80

Low:582.75

Close:661.55

Volume:40.20M

Turnover:700.78M

Market Cap:18.07B

Float Cap:13.43B

Loading ...

Shareholders Approve New Incentive Plan and Governance Measures

Recursion Pharma director Bumpus Namandje disposes of 4,386 common shares for $15,526.44

Recursion Pharma director Blake Borgeson disposes of 30,000 shares worth $110,400

CRISPR Therapeutics shareholders approve 2026 stock option and incentive plan at annual meeting

Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Crispr Therapeutics AG (CRSP)

Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350

Tempus AI launches open-source digital pathology consortium

Recursion to Present at Goldman Sachs Global Healthcare Conference

Recursion to Participate in Upcoming Investor Conferences

Tempus AI assumed with a Peer Perform at Wolfe Research

Tempus AI announced the upcoming clinical availability of xH

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh

THOMSON REUTERS

Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026

Tempus AI Price Target Maintained With a $80.00/Share by BTIG

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)

Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)

Short Report: Tempus AI short interest at record high

Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":592.54724,"timestamp":1780689599999,"preClose":661.55096,"halted":0,"volume":40204021,"delay":0,"changeRate":-0.104306,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-69.003723,"latestTime":"06-05 16:00:00 EDT","open":657.797,"high":657.797,"low":582.74786,"amount":700784648.533977,"amplitude":0.113444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780704000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.148537,"peRate":-12.247681,"turnoverRate":0.057668,"increases":0,"decrements":4,"flats":0,"marketCap":18074683136,"floatMarketCap":13434409984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":657.797,"amplitude":0.113444,"preClose":661.55096,"low":582.74786,"pbRate":"4.148537","latestPrice":592.54724,"volume":40204021,"delay":0,"open":657.797,"prevYearClose":658.3995,"prevWeekClose":647.3484,"prevMonthClose":647.3484,"prevQuarterClose":542.5347,"fiveDayClose":647.3484,"twentyDayClose":616.2853,"sixtyDayClose":600.6132,"secType":"PLATE","market":"US","turnoverRate":0.057668,"peRate":-12.247681,"marketCap":18074683136,"floatMarketCap":13434409984,"timestamp":1780689599999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":0,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641198649","title":"Shareholders Approve New Incentive Plan and Governance Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2641198649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641198649?lang=en_us&edition=fundamental","pubTime":"2026-06-05 06:52","pubTimestamp":1780613573,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has provided an update. On June 4, 2026, CRISPR Therapeutics shareholders approved a new 2026 Stock Option and I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shareholders-approve-new-incentive-plan-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shareholders-approve-new-incentive-plan-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","CRSP","BK4588","BK4585","LU1861558580.USD","BK4556","LU1861559042.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641278167","title":"Recursion Pharma director Bumpus Namandje disposes of 4,386 common shares for $15,526.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2641278167","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641278167?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:05","pubTimestamp":1780607142,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals director Bumpus Namandje sold 4,386 Class A common shares on June 3 at USD 3.54.Holdings fell to 43,171 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL317yjf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","RXRX","BK4611","BK4139","BK4609","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641716722","title":"Recursion Pharma director Blake Borgeson disposes of 30,000 shares worth $110,400","url":"https://stock-news.laohu8.com/highlight/detail?id=2641716722","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641716722?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:05","pubTimestamp":1780607127,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals director Blake Borgeson sold 30,000 Class A common shares on June 2, 2026 at USD 3.68.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4FhC3B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma director Blake Borgeson disposes of 30,000 shares worth $110,400","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4539","BK4609","BK4139","BK4548","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641167608","title":"CRISPR Therapeutics shareholders approve 2026 stock option and incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641167608","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641167608?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:46","pubTimestamp":1780605977,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics held its annual general meeting on June 4, 2026.Shareholders adopted the 2026 Stock Option and Incentive Plan, authorizing awards such as options, stock appreciation rights, restricted stock, and RSUs.Amendments to the articles of association were adopted; effectiveness was tied to subsequent registration and approvals, not confirmed as completed.Shareholders endorsed the 2025 Swiss management report, consolidated financial statements, statutory financial statements, and the carryforward of the net loss.Auditors were reappointed; the independent voting rights representative was reappointed; an expanded capital band and higher conditional share capital for bond conversions were authorized.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL4TXjlq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP","LU1861559042.SGD","BK4588","BK4556","BK4139","BK4585","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640159863","title":"Analysts Are Bullish on Top Healthcare Stocks: Insulet (PODD), Crispr Therapeutics AG (CRSP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640159863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640159863?lang=en_us&edition=fundamental","pubTime":"2026-06-04 18:00","pubTimestamp":1780567243,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD) and Crispr Therapeutics AG (CRSP) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-insulet-podd-crispr-therapeutics-ag-crsp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-insulet-podd-crispr-therapeutics-ag-crsp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU2065170008.USD","LU2324357040.USD","BK4611","LU2065171311.SGD","LU1119994496.HKD","BK4556","LU2065169927.USD","LU2065171402.SGD","LU1084165304.USD","BK4585","BK4551","BK4588","LU0728928796.USD","LU1861559042.SGD","BK4566","PODD","LU1861558580.USD","BK4139","CRSP","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640812131","title":"Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350","url":"https://stock-news.laohu8.com/highlight/detail?id=2640812131","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640812131?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:29","pubTimestamp":1780518569,"startTime":"0","endTime":"0","summary":"Tempus AI director David R. Epstein sold 250 shares of Class A common stock on June 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL4V3lcY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI director David R. Epstein reports disposal of 250 common shares worth $12,350","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","BK4611","TEMT","BK4613","LU1861559042.SGD","LU1861558580.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640018356","title":"Tempus AI launches open-source digital pathology consortium","url":"https://stock-news.laohu8.com/highlight/detail?id=2640018356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640018356?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:31","pubTimestamp":1780500694,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM), Yale New Haven Hospital, and Memorial Sloan Kettering Cancer Center announced the launch of a digital pathology IMS Open-Source Co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-launches-open-source-digital-pathology-consortium-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-launches-open-source-digital-pathology-consortium-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4121","LU1861559042.SGD","TEM","BK4611","TEMT","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640948527","title":"Recursion to Present at Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640948527","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640948527?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:12","pubTimestamp":1780402331,"startTime":"0","endTime":"0","summary":"Recursion will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL3bvRzK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004091025.USD","BK4548","LU2750360997.AUD","LU0868494617.USD","LU0048573561.USD","BK4609","LU1804176565.USD","IE0034235188.USD","LU0345770308.USD","BK4127","LU2471134523.USD","LU2471134879.HKD","BK4516","IE00BFXG1179.USD","LU2750360641.GBP","LU0345770993.USD","LU1868836757.USD","LU0251131958.USD","LU2237443622.USD","LU1668664300.SGD","LU1791807156.HKD","BK4139","IE0004086264.USD","LU2237443465.HKD","LU0742534661.SGD","LU2237438978.USD","LU2237443895.HKD","LU1868837300.USD","IE00B19Z3B42.SGD","GS","LU0251142724.SGD","BK4533","LU0868494708.USD","LU1868837136.USD","LU2237443549.SGD","BK4539","BK4552","BK4611","LU2237443978.SGD","LU1868836591.USD","LU2237443382.USD","GSX","BK4550","BK4504","IE00BSNM7G36.USD","LU0061475181.USD","LU2471134952.CNY","RXRX","LU0096364046.USD","IE00B19Z3581.USD","LU2265009873.SGD","LU1868836914.USD","BK4585","LU1894683348.USD","LU2471134796.USD","LU0106831901.USD","LU1894683264.USD","IE0002270589.USD","LU0942090050.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2640394886","title":"Recursion to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2640394886","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640394886?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:00","pubTimestamp":1780401600,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals. media@recursion.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305112/0/en/Recursion-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RXRX","BK4548","BK4539","BK4609","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640962797","title":"Tempus AI assumed with a Peer Perform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640962797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640962797?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:50","pubTimestamp":1780347018,"startTime":"0","endTime":"0","summary":"Wolfe Research assumed coverage of Tempus AI (TEM) with a Peer Perform rating and no price target The company’s data offering is “differentiated” v...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-assumed-with-a-peer-perform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-assumed-with-a-peer-perform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","TEMT","TEM","BK4121","BK4613","BK4611","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696862","title":"Tempus AI announced the upcoming clinical availability of xH","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640696862?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:49","pubTimestamp":1780325355,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced the upcoming clinical availability of xH, a next-generation sequencing, NGS, test that uses a whole-genome sequencing, WG...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announced-the-upcoming-clinical-availability-of-xh-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announced-the-upcoming-clinical-availability-of-xh-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMT","BK4611","BK4613","BK4121","LU1861558580.USD","TEM","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951441","title":"Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, Xh","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951441?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:33","pubTimestamp":1780317227,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290HM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEM","BK4613","LU1861558580.USD","BK4611","BK4121","TEMT","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959423","title":"Guggenheim Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959423?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:59","pubTimestamp":1780315153,"startTime":"0","endTime":"0","summary":"In a report released today, Subbu Nambi from Guggenheim maintained a Buy rating on Tempus AI, Inc. Class A, with a price target of $60.00. Nambi co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-reaffirms-their-buy-rating-on-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","BK4121","TEMT","LU1861559042.SGD","BK4611","TEM","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959336","title":"Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959336","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959336?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., June  01, 2026  (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304241/0/en/Intellia-Therapeutics-to-Report-Additional-Phase-3-HAELO-Data-for-Lonvoguran-Ziclumeran-lonvo-z-in-Late-Breaking-Oral-Presentation-at-EAACI-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HAE","BK4139","IE0034390439.USD","IE00B64QTZ34.USD","LU0012050646.USD","IE0009354923.USD","LU1169589451.USD","LU0106261612.USD","LU1861559042.SGD","BK4535","BK4611","BK4588","BK4556","NTLA","BK4585","IE00BLDYK493.USD","BK4198","LU1861558580.USD","ODD","LU0205194284.USD","BK4183","LU1169590202.USD","IE00B19Z6F94.USD","CRSP","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640881955","title":"Tempus AI Price Target Maintained With a $80.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2640881955","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640881955?lang=en_us&edition=fundamental","pubTime":"2026-06-01 18:44","pubTimestamp":1780310640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 06:44 ET (10:44 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU1861558580.USD","TEMT","BK4611","LU1861559042.SGD","TEM","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640893728","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640893728","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640893728?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:20","pubTimestamp":1780305650,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-tempus-ai-inc-class-a-tem-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-tempus-ai-inc-class-a-tem-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1551013425.SGD","LU0203201768.USD","IE00BN29S564.USD","LU2324357040.USD","LU2168564495.EUR","IE0001KFT4U8.USD","LU1917777945.USD","LU1868836757.USD","IE00BKDWB100.SGD","LU1035775433.USD","LU2111349929.HKD","SG9999014906.USD","LU0316494557.USD","SG9999015978.USD","LU1551013342.USD","LU0353189763.USD","IE00BJT1NW94.SGD","LU1280957306.USD","SG9999001176.USD","LU2237443465.HKD","LU2491050071.SGD","ELIS","LU0320765992.SGD","LU1868836591.USD","LU1868836914.USD","LU1057294990.SGD","LU2108987350.USD","BK4585","IE00B1BXHZ80.USD","LU0820562030.AUD","LU1712237335.SGD","LU2471134879.HKD","LU2756315318.SGD","LU1291159041.SGD","LU0289739699.SGD","LU1366192091.USD","LU1232071149.USD","LU2168564065.EUR","LU1093756325.SGD","LU2360106947.USD","LU0256863902.USD","LU0097036916.USD","IE00B2B36J28.USD","LU0353189680.USD","IE00BJJMRX11.SGD","LU0323591593.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0096364046.USD","LU1023059063.AUD","IE00BJJMRY28.SGD","LU0266013472.USD","LU0456855351.SGD","LU1629891620.HKD","LU0708995401.HKD","LU2237438978.USD","LU0061475181.USD","LU1861558580.USD","LU0198837287.USD","LU0882574139.USD","LU0889565916.HKD","LU1720051017.SGD","LU2265009873.SGD","LU0109391861.USD","SG9999015945.SGD","LU2023251221.USD","IE0002141913.USD","LU1061106388.HKD","LU2087625088.SGD","LU2750360997.AUD","LU2471134523.USD","IE0009355771.USD","LU1093756168.USD","LU2361045086.USD","LU1720051108.HKD","LU2168563687.JPY","IE00B1XK9C88.USD","LU1623119135.USD","LU0683600562.USD","LU0094547139.USD","BK4534","LU0133085943.USD","LU2023250504.SGD","LU2750360641.GBP","LU2756315664.SGD","LU0943347566.SGD","LU2896262040.SGD","LLYX","LU2213496289.HKD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","BK4550","LU1974910355.USD","SG9999014880.SGD","LU0225283273.USD","ELIL","LU0786609619.USD","LU0417517546.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU0787776722.HKD","LU1267930730.SGD","LU2237443622.USD","LU0238689110.USD","LU2089284900.SGD","LU0106261372.USD","LU2237443978.SGD","LU2746668461.USD","LU2552382215.SGD","LU2461242641.AUD","BK4613","LU0354030511.USD","LU0471298694.HKD","SG9999018865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0689472784.USD","LU0006306889.USD","LU0210536198.USD","LU2237443895.HKD","LU2361044865.SGD","LU2168564222.USD","LU2089283258.USD","SG9999014898.SGD","LU0158827781.USD","LU1814569148.SGD","LU2106854487.HKD","BK4121","SG9999015986.USD","LU0820561909.HKD","LU2491049909.HKD","SG9999013999.USD","IE00BK4W5L77.USD","LU2491050154.USD","BK4139","BK4533","BK4532","IE00BJJMRZ35.SGD","BK4611","LU0823416689.USD","LU2168564149.EUR","LU2417539215.USD","LU0203202063.USD","LU1127390331.HKD","IE00BFSS8Q28.SGD","LU2471134796.USD","LU0158827948.USD","LU2746668974.SGD","LU1868837300.USD","IE00BKPKM429.USD","LU2063271972.USD","LU2456880835.USD","BK4581","LU0640476718.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU2237443549.SGD","LU2264538146.SGD","IE0004445239.USD","LU2471134952.CNY","LU2468319806.SGD","LU0882574055.USD","LU0058720904.USD","SG9999017495.SGD","SGXZ57979304.SGD","LU0964807845.USD","LU1988902786.USD","LU1323610961.USD","LU1868837136.USD","LU1989771016.USD","LU2028103732.USD","LU0256863811.USD","LU2237443382.USD","IE00B4R5TH58.HKD","BK4588","LU0466842654.USD","LU2357305700.SGD","TEM","LU2361044949.HKD","SGXZ31699556.SGD","BK4516","LU1804176565.USD","LU0122379950.USD","LU0114720955.EUR","LU1069344957.HKD","LU1861559042.SGD","LU2089984988.USD","SG9999014914.USD","SG9999018857.SGD","BK4007","LU0354030438.USD","GB00BDT5M118.USD","LU2462157665.USD","TEMT","LLY","LU0079474960.USD","IE00BFSS7M15.SGD","LU0432979614.USD","SGXZ99366536.SGD","IE0004445015.USD","IE00B775H168.HKD","LU2112291526.USD","LU2211815571.USD","LLYZ","LLII","LU2602419157.SGD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU1064131342.USD","LU1548497426.USD","LU0823434740.USD","LU1983299246.USD","LU2023250330.USD","SG9999001176.SGD","IE0005OL40V9.USD","IE00BK4W5M84.HKD","LU0234572021.USD","LU2552382132.HKD","LU0820561818.USD","BK4599","INCY","LU0471298777.SGD","LU2271345857.HKD","LU2236285917.USD","LU0320765059.SGD","LU0385154629.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640934707","title":"Tempus AI Launches Next-Generation Agentic AI Platform for Oncology Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2640934707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640934707?lang=en_us&edition=fundamental","pubTime":"2026-06-01 16:35","pubTimestamp":1780302955,"startTime":"0","endTime":"0","summary":"Tempus AI  has introduced the next-generation of its agentic AI platform for oncology drug development, Lens, the company said over the weekend.The platform was designed to help drug development teams to design better clinical trials, target patient subgroups, and generate evidence more quickly, Tempus AI said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861559042.SGD","BK4611","TEM","BK4613","BK4121","LU1861558580.USD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640849739","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640849739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640849739?lang=en_us&edition=fundamental","pubTime":"2026-06-01 09:20","pubTimestamp":1780276807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-krystal-biotech-krys-abbvie-abbv-and-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-krystal-biotech-krys-abbvie-abbv-and-tempus-ai-inc-class-a-tem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU0310800379.SGD","IE00B19Z3B42.SGD","BK4121","IE00BDGV0183.EUR","IE00BSNM7G36.USD","LU0949170772.SGD","LU1061106388.HKD","LU0545039389.USD","IE0004445239.USD","LU0456855351.SGD","LU1983299246.USD","LU1670628061.USD","LU0738911758.USD","LU0868494708.USD","ABBV","LU0432979614.USD","LU2129689605.HKD","SG9999001440.SGD","LU0057025933.USD","LU0859254822.USD","LU1496350171.SGD","LU0511384066.AUD","LU0823416689.USD","TEMT","LU1496350502.SGD","LU1003077747.HKD","SG9999015978.USD","LU2133065610.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4566","LU0098860793.USD","LU1670627923.USD","LU0689626769.HKD","LU0820561818.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1244550494.USD","LU0965508806.USD","BK4550","IE00B42XCP33.USD","LU0689472784.USD","LU1934455194.USD","LU0472753341.HKD","LU2347655156.SGD","LU0029864427.USD","SG9999015986.USD","LU0661504455.SGD","LU0289961442.SGD","LU0320765646.SGD","IE0000B7K699.USD","LU2357627491.SGD","BK4585","LU0417517546.SGD","LU0170899867.USD","IE00B3PB1722.GBP","LU0256863811.USD","IE00BFTCPJ56.SGD","TEM","LU1929549753.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU1291159041.SGD","LU0795875169.SGD","LU1057294990.SGD","LU1430594728.SGD","LU0058720904.USD","BK4533","BK4581","IE00BLSP4239.USD","LU1244550221.USD","LU0234572021.USD","LU1093756168.USD","LU2023251221.USD","IE00BVYPNW00.USD","LU2089283258.USD","IE000MB6IJN5.SGD","LU0198837287.USD","LU0211328371.USD","IE00BGHQF631.EUR","LU1934455863.HKD","LU2237443895.HKD","BK4559","IE0002270589.USD","LU0128525929.USD","LU1037948541.HKD","IE00BN8TJ469.HKD","LU0795875086.SGD","LU2237443622.USD","IE00B4R5TH58.HKD","SG9999011175.SGD","LU0158827948.USD","LU1732799900.SGD","LU1989772923.USD","LU0965509010.AUD","LU1585245621.USD","LU0868494617.USD","IE000BZT7R73.USD","LU2087621335.USD","LU2129689514.USD","IE0009355771.USD","IE000F7OJYX1.SGD","LU1989772840.SGD","LU1267930490.SGD","LU0122379950.USD","LU2129689431.USD","LU1551013342.USD","LU1839511570.USD","LU0708994859.HKD","LU0310799852.SGD","LU1718418525.SGD","LU0553294199.USD","SG9999015945.SGD","BK4613","SG9999003800.SGD","LU0965509101.SGD","LU0124676726.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU0211327993.USD","IE00BVYPNV92.GBP","LU0289739343.SGD","LU0289739699.SGD","LU1989771016.USD","LU1244550577.SGD","LU0069063385.USD","LU1732800096.USD","LU0943347566.SGD","LU0234570918.USD","BK4611","LU0861579265.USD","LU1074936037.SGD","LU0912757837.SGD","LU0256863902.USD","LU1162221912.USD","LU2089284900.SGD","SG9999015952.SGD","LU1861558580.USD","LU2089984988.USD","LU1934455277.USD","LU0882574055.USD","IE000WAW04H5.SGD","LU1861559042.SGD","LU0203347892.USD","LU1037948897.HKD","LU0985320562.USD","IE0002141913.USD","LU1093756325.SGD","LU0942090050.USD","IE000SO60NU8.SGD","LU0965509283.SGD","LU1267930573.SGD","LU2237443549.SGD","LU0203345920.USD","BK4139","LU0820561909.HKD","LU1551013425.SGD","KRYS","LU2237443382.USD","BK4534","LU2237443978.SGD","BK4588","LU2112291526.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640625986","title":"Short Report: Tempus AI short interest at record high","url":"https://stock-news.laohu8.com/highlight/detail?id=2640625986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640625986?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:05","pubTimestamp":1780261557,"startTime":"0","endTime":"0","summary":"Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest trends among some of the most widely f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/short-report-tempus-ai-short-interest-at-record-high-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/short-report-tempus-ai-short-interest-at-record-high-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4613","BK4121","TEM","LU1861559042.SGD","TEMT","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988179","title":"Tempus AI announces launch of PRECISION Challenge for oncology breakthroughs","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988179?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:35","pubTimestamp":1780234504,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced the launch of the PRECISION Challenge, an initiative engineered to accelerate the next generation of oncology breakthroug...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-launch-of-precision-challenge-for-oncology-breakthroughs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-launch-of-precision-challenge-for-oncology-breakthroughs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","LU1861558580.USD","BK4613","BK4611","BK4121","LU1861559042.SGD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}